Clinical Trial Update: Pulmicort Turbuhaler 100/200 Specific Clinical Experience Investigation

View source ↗

Summary

Clinical trial update on Pulmicort Turbuhaler (budesonide) for bronchial asthma; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Pulmicort Turbuhaler 100/200 (budesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Bronchial Asthma | Status: COMPLETED